All In MedTech

Device Trial Radar · NCT03015649

Long Term Use of SAVI SCOUT: Pilot Study

Evaluation of Longer Duration Use of the SAVI SCOUT Surgical Guidance System for Excision of Breast and Axillary Lesions in Neo-adjuvant Therapy Patients: A Pilot Study

Last checked: Nov 19, 2026Latest source record: May 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

34

Actual

Start

Feb 3, 2017

Primary completion

Sep 10, 2018

Study completion Apr 4, 2019

Sponsor

Lead sponsor
Envision Healthcare Scientific Intelligence, Inc.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Cianna Medical, Inc.
First posted
Jan 10, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Health services research
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the performance of FDA-cleared SAVI SCOUT Breast Localization and Surgical Guidance System (SCOUT) over a longer duration prior to surgery. The device is a non-wire system, which uses nonradioactive light-activated radar, to provide breast surgeons with real-time guidance to locate and remove the target lesion in the breast and/or axillary tissue. The SCOUT device standard of care use is placement up to 30 days prior to surgery to assist surgeons in the localization and retrieval of breast/axillary lesions. Routine image-guided methods (Mammography, Ultrasound, and CT) are used. In this study, investigators will assess the longer term placement of the SCOUT device over an extended time (31 - 365 days) in order to address the needs of patients who require neoadjuvant treatment prior to definitive surgery.

Conditions

  • Breast Diseases

Interventions

  • SAVI SCOUT Surgical Guidance SystemDevice

    SAVI SCOUT Surgical Guidance System is a non-wire system, which uses nonradioactive light-activated radar, to provide breast surgeons with real-time guidance to locate and remove the target lesion in the breast and/or axillary tissue.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Considered to Have a Successful SurgeryTime frame: 31 - 365 days prior to surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Envision Physician Scientific Research, Inc. formerly Sheridan Healthcare, Inc.

    Plantation, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.